Tag Archives: infant formula

UK – Aptamil – Factory All Clear – Campylobacter

Dairy Reporter

Aptamil infant formula linked to a case of Campylobacter illness in a British infant was given the “all clear” before entering the market.

 

Canada – CFIA – Updated Recall – Staph Toxin in Cheese – Infant Formula – Possible Contamination

CFIA

The food recall warning issued on July 4, 2014 has been updated to include additional products. This additional information was identified during the Canadian Food Inspection Agency’s (CFIA) food safety investigation.

Fromagerie Le Détour (2003) Inc. is recalling Citadelle and Grey Owl cheese from the marketplace because they may contain the toxin produced by Staphylococcus bacteria. Consumers should not consume the recalled products described below.

Also affected by this alert are th products listed in the link above which may have been sold in smaller packages, cut and wrapped by some retailers. Consumers are advised to contact the retailer to determine if they have the affected products.

CFIA

The Canadian Food Inspection Agency (CFIA), Walmart Canada Corporation and Mead Johnson Nutrition (Canada) Company are advising the public that some bottles of Enfamil A+ Ready-to-Feed Infant Formula have been found with the tamper-proof seal broken and blue tape applied in its place. These bottles were found to contain water and some formula residue instead of infant formula.

A total of three complaints have been reported in Brampton and Mississauga.

Walmart immediately removed the product from sale in a number of stores in the Halton and Peel regions of Toronto and did not find any additional product that had been altered

USA – Microbial Testing Now Required for Infant Formula

Food Poisoning JournalFDA

The U.S. Food and Drug Administration published an interim final rule to further safeguard the health of infants fed infant formula in the United States. The rule, which sets standards for manufacturers to produce safe infant formula that supports healthy growth, is accompanied by two draft guidance documents for industry.

The interim final rule amends the FDA’s quality control procedures, notification, and record and reporting requirements for manufacturers of applicable infant formula products. The rule, in part, will ensure that infant formula contains all federally required nutrients. The interim final rule also establishes current good manufacturing practices specifically designed for infant formula, including required testing for microbial contamination. This microbial testing includes testing representative samples of finished products to prevent the distribution of infant formula products contaminated with the pathogens Cronobacter and Salmonella. The interim final rule also establishes quality factor requirements to support healthy growth.

Companies currently manufacturing infant formula in the United States already voluntarily conduct many of the current good manufacturing practices and quality control procedures included in the interim final rule. Following publication of the rule, the FDA will be accepting and reviewing comments on issues or information not previously considered.

The FDA is accepting comments from the public on the interim final rule for 45 days at http://www.regulations.gov (Docket Number FDA-1995-N-0036).